Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alloimmune Platelet Refractoriness”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)UnknownNCT04846439
What this trial is testing

Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL

Who this might be right for
Platelet Transfusion RefractorinessAcute Leukemia in Remission
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT02298933
What this trial is testing

Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia

Who this might be right for
ThrombocytopeniaAlloimmune Platelet Refractoriness
National Heart, Lung, and Blood Institute (NHLBI) 10

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation